Aminoglutethimide
- TRADE NAMES: Cytadren (Novartis); Orimeten; Orimetene; Rodazol
- INDICATIONS: Suppression of adrenal function, metastatic carcinoma
- CLASS: Aromatase inhibitor
- HALF-LIFE: 7–15 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Betamethasone, Dexamethasone, Doxercalciferol, Oxtriphylline, Triamcinolone
PREGNANCY CATEGORY: D
Please login to see the rest of this drug profile
SKIN.
HAIR.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric